1Eto M, Toba K, AkishitaM, et al. Impact of blood pressure variability on cardiovascular events in elderly patients with hypertension [J]. Hypertens Res, 2005, 25 (1): 1-7.
2Verdecchia P, Angeli F, Gattobigio R, et al. Impact of blood pressure variability on cardiac and cerebrovascular complications in hypertension [J]. Am J Hypertens, 2007, 20: 154-161.
3Tatasciore A, Renda G, Zimarino M, et al. Awake systolic blood pressure variability correlates with targetorgan damage in hypertensive subjects [J]. Hypertension, 2007, 50: 325-332.
4Lefebvre J, Poirier L, Archambauh F, et al. Comparative effets of felodopine ER, amlodipine and nifedipine GITS on 24h blood pressure control and trough to peak ratios in mild to moderate ambulatoryhypertension: a forced titration study [J]. Can J Cardiol, 1998, 14 (5): 682-688.
5AMbers J. Reduced blood pressure variability in ASCOT-BPLA trial favours use of amlodipine/perindopril combination to reduce stroke risk [J]. Cardiovasc J Mr, 2010, 21 (2): 151.
6Rothwell PM, Howard SC, Dolan E, et al. Effects of beta blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke [J]. Lancet Neurol, 2010, 9 (5) : 469-480.
7Zhang XP, Loke KE, Mital S, et al. Paradoxical release of nitricoxide by an L-type calcium channel antagonist, the R+enantiomer of amlodipine [J]. J Cardiovasc Pharmacol, 2002, 39 (2): 208- 214.
